Norden Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Sell
2,619
-1,493
-36% -$209K 0.03% 462
2025
Q4
$674K Buy
4,112
+1,744
+74% +$273K 0.07% 275
2025
Q3
$317K Buy
+2,368
New +$288K 0.03% 457
2025
Q2
Sell
-2,549
Closed -$324K 581
2025
Q1
$324K Sell
2,549
-1,149
-31% -$177K 0.04% 405
2024
Q4
$532K Buy
3,698
+341
+10% +$48.9K 0.06% 316
2024
Q3
$500K Sell
3,357
-573
-15% -$82.2K 0.06% 319
2024
Q2
$495K Buy
3,930
+958
+32% +$150K 0.1% 217
2024
Q1
$547K Buy
2,972
+830
+39% +$158K 0.11% 211
2023
Q4
$385K Buy
2,142
+749
+54% +$117K 0.07% 167
2023
Q3
$222K Buy
+1,393
New +$228K 0.07% 226

Other funds holding RGEN

Norden Group's RGEN Position: Q1 2026 in Review

Norden Group reduced its Repligen (RGEN) stake by 36% in Q1 2026, selling an estimated $209K and leaving 2,619 shares worth $309K. The position accounts for 0.03% of the portfolio, ranked #462.

Norden Group first reported a position in RGEN in Q3 2023 and has held it in 10 quarters since. The position peaked at $674K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Norden Group held 2,619 shares of Repligen worth $309K as of Q1 2026.
  • Norden Group sold 1,493 Repligen shares in Q1 2026, an estimated $209K.
  • Repligen made up 0.03% of Norden Group's portfolio in Q1 2026, its #462 holding.
  • Norden Group first reported a position in Repligen in Q3 2023 and has held it in 10 quarters since.
  • Norden Group's Repligen position peaked at $674K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.